Prescott Group Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.13M Buy
2,105,502
+330,000
+19% +$774K 0.41% 70
2025
Q4
$4.81M Buy
+1,775,502
New +$5.83M 0.45% 60
2025
Q3
Sell
-80,000
Closed -$398K 245
2025
Q2
$398K Hold
80,000
0.05% 228
2025
Q1
$353K Sell
80,000
-54,660
-41% -$257K 0.05% 202
2024
Q4
$626K Buy
134,660
+40,000
+42% +$220K 0.09% 206
2024
Q3
$657K Buy
+94,660
New +$743K 0.1% 190

Other funds holding GDRX

Prescott Group Capital Management's GDRX Position: Q1 2026 in Review

Prescott Group Capital Management increased its GoodRx Holdings (GDRX) stake by 19% in Q1 2026, buying an estimated $774K and bringing the position to 2,105,502 shares worth $4.13M. The position accounts for 0.41% of the portfolio, ranked #70.

Prescott Group Capital Management first reported a position in GDRX in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.81M in Q4 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Prescott Group Capital Management held 2,105,502 shares of GoodRx Holdings worth $4.13M as of Q1 2026.
  • Prescott Group Capital Management bought 330,000 GoodRx Holdings shares in Q1 2026, an estimated $774K.
  • GoodRx Holdings made up 0.41% of Prescott Group Capital Management's portfolio in Q1 2026, its #70 holding.
  • Prescott Group Capital Management first reported a position in GoodRx Holdings in Q3 2024 and has held it in 6 quarters since.
  • Prescott Group Capital Management's GoodRx Holdings position peaked at $4.81M in Q4 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Prescott Group Capital Management's 13F filing for Q1 2026, filed 7 May 2026.